Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology ...
Aktis Oncology Inc., a clinical-stage biotechnology company focused on using so-called radiopharmaceuticals for treatments, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--MPM Capital (MPM), one of the world’s prominent biotech investment firms, has announced the addition of Detlev Biniszkiewicz, Ph.D. to its venture investment team as ...
CAMBRIDGE, Mass. – Semma Therapeutics, a company developing a cell therapy for Type 1 diabetes, announced today that it has closed a $44 million Series A consisting of equity financing and strategic ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
MPM Capital and Dana-Farber Cancer Institute have formed a venture philanthropy alliance, raising a $100 million investment fund and $26 million in donations to support early stage research.
Those who have a thing for rare and quirky vehicles will love the MPM PS160 / Erelis, a now-discontinued and quite affordable four-door coupe from Europe which remains largely unknown to most of the ...
Partners Group has agreed to buy UK pet-food business MPM Products from its UK private-equity peer 3i. Established 2002, Manchester-based MPM’s portfolio includes cat-focused brands such as Applaws, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback